- Home
- COYA vs DMO Comparison
COYA vs DMO Comparison
Compare COYA & DMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COYA | DMO |
|---|---|---|
| Founded | 2020 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.6M | 131.8M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | COYA | DMO |
|---|---|---|
| Price | $5.25 | $11.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.80 | N/A |
| AVG Volume (30 Days) | ★ 225.7K | 49.6K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.06% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,987,706.00 | N/A |
| Revenue This Year | $69.95 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.65 | $10.00 |
| 52 Week High | $8.29 | $11.80 |
Technical Indicators
Market Signals| Indicator | COYA | DMO |
|---|---|---|
| Relative Strength Index (RSI) | 39.62 | 37.17 |
| Support Level | $5.29 | $10.92 |
| Resistance Level | $5.93 | $11.09 |
| Average True Range (ATR) | 0.40 | 0.11 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 10.26 | 15.09 |
Price Performance
Historical ComparisonAbout COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About DMO Western Asset Mortgage Opportunity Fund Inc.
Western Asset Mortgage Defined Opportunity Fund Inc is a non-diversified, limited-term, closed-end management investment company. The fund's primary investment objective is to provide current income. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing in a diverse portfolio of mortgage-backed securities, consisting of non-agency residential mortgage-backed securities and commercial mortgage-backed securities.